← SynDRA
BI-78D3
SynDRA canonical compound SYN0086595 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAPK8 |
|---|
| Mechanism of action | JNK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RefChem:917140
- DTXCID60323661
- MFCD01313575
- MLS006010634
- orb1300469
- SCHEMBL8187066
- SCHEMBL10082849
- SCHEMBL29404340
- SCHEMBL29461370
- BDBM26057
- C13H9N5O5S2
- CHEBI:94732
- EX-A970
- GLXC-03951
- HMS3413H22
- HMS3677H22
- BI-78D3?
- BDBM50526695
- CCG-56351
- s8201
- AKOS016006596
- CCG-268395
- CS-5718
- NCGC00263145-01
- AC-35341
- AS-55913
- HY-10366
- SMR004701639
- BI-78D3, >=98% (HPLC)
- T6784
- F232418
- SR-01000645315-1
- BRD-K73982490-001-01-1
- BRD-K73982490-001-02-9
- BRD-K73982490-001-03-7
- 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-2-thiazolyl)thio]-1H-1,2,4-triazol-5-one
Look up BI-78D3 in the interactive SynDRA portal →